article thumbnail

Who’s hiring who? Hiring activity related to digital media decreased by 5% in the pharmaceutical industry in Q3 2022

Pharmaceutical Technology

Market Research Analysts and Marketing Specialists came in second with a share of 6% in Q3 2022, with new job postings rise by 18% over the previous quarter. The global pharmaceutical industry experienced a 5% rise in new job postings related to digital media in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to a 5% increase in the previous quarter and an 166% increase versus Q3 2021.

article thumbnail

Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding

The Pharma Data

The latest results underscore that large pharma companies are making a “strategic retreat from some of their older drugs,” in China, ICBC International Research analyst Zhang Jialin said, as quoted by Bloomberg; instead, they’re focusing on growing market share for newer medicines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”.

article thumbnail

Retail Sales of Plant-Based Foods Surged to $7 Billion in 2020

XTalks

Kyle Gaan, a research analyst at GFI said in the same press release, “2020 was a breakout year for plant-based foods across the store.

Sales 83
article thumbnail

More Positive Data for Eli Lilly’s Diabetes and Weight Loss Injection Tirzepatide

XTalks

Tirzepatide’s continuing stellar trial results as a weight loss injection have industry analysts putting up big predictions for the drug, particularly as a rival to Novo’s obesity drug Wegovy (tirzepatide is currently only approved for the treatment of type 2 diabetes under the trade name Mounjaro).

article thumbnail

Novotech Health Holdings Appoints Zidong Zhang as CFO

The Pharma Data

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. Prior to that, Dr. Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. SHANGHAI and SYDNEY , Dec.

article thumbnail

BioSpace Movers & Shakers, Jan. 1

The Pharma Data

Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. Prior to Raptor, Lee was a biotechnology sell-side analyst at investment banks, including Jefferies and Wedbush Securities.